Phytomedicine: International Journal of Phytotherapy & Phytopharmacology - The inhibition of Candida species by selected essential oils and their synergism with Amphotericin B
August 1, 2008 -- Abstract In this work we highlight a possible synergistic anti-Candida effect between Melaleuca alternifolia, Origanum vulgare and Pelargonium...
Internal Medicine News - Aerosol amphotericin B in the works as fungal prophylaxis
May 1, 2006 -- LAS VEGAS -- An inhaled formulation of amphotericin B in clinical development may answer the unmet need for antifungal prophylaxis in...
Business Wire - BioDelivery Sciences Initiates Bioral® Amphotericin B Clinical Program
July 28, 2008 -- Phase I trial represents the first clinical study in humans utilizing the Company's Bioral([R]) drug delivery technology RALEIGH, N.C. --...
Nursing - Amphotericin B reaction
November 1, 2000 -- A 33-YEAR-OLD MAN was being treated for meningitis with amphotericin B through an intraventricular reservoir. Despite pretreatment medications, he...
Phytomedicine: International Journal of Phytotherapy & Phytopharmacology - Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans
November 1, 2007 -- Abstract Amphotericin B (Amp B) is considered as a drug of choice for treatment of fungal infections, but it causes severe side effects such as...
Skin & Allergy News - Advanced antifungal safer than amphotericin B
June 1, 2003 -- Caspofungin is as effective as the tried and true--but potentially toxic--amphotericin B for treating invasive candidiasis, said Dr. Jorge...
Southern African Journal of HIV Medicine - Treatment of HIV-associated cryptococcal meningitis in South Africa: the case for amphotericin B over conventional dose fluconazole for initial therapy
March 22, 2007 -- Cryptococcal meningitis is a major cause of morbidity and mortality in African AIDS patients, accounting for between 13% and 17% of deaths in Ugandan...
Business Wire - Amphotericin B the First Antifungal Drug Approved by the US is Still Used Despite Its Toxicity Problems
March 14, 2006 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c31571) has announced the addition of Advances in the Treatment of...
M2 Presswire - Amphotericin B the first antifungal drug approved by the US is still used despite its toxicity problems.
March 14, 2006 -- M2 PRESSWIRE-14 March 2006-Research and Markets: Amphotericin B the first antifungal drug approved by the US is still used despite its toxicity...
Photochemistry and Photobiology - Potentiation of the Antitumor Effect of Merocyanine 540-mediated Photodynamic Therapy by Amifostine and Amphotericin B
March 1, 2006 -- ABSTRACT Leukemia and lymphoma cells are much more sensitive to Merocyanine 540 (MC540)-mediated photodynamic therapy (PDT) than normal pluripotent...
